SEC Form 4 · accession 0001642247-17-000018
Perspective Therapeutics, Inc. · CATX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Branson
Officer — Principal Fin & Acct Officer
Period of report
Jun 15, 2017
Accepted (ET)
Jul 6, 2017 · 3:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000728387
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $1.53 | Jun 15, 2017 | D | 15,000 | D | — | Mar 10, 2025 | Common Stock | 15,000 | 0 | D |
| Stock Options (right to buy)F1 | $0.93 | Jun 15, 2017 | D | 25,000 | D | — | Jun 21, 2026 | Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1The two reported transactions involved a termination of two outstanding options, resulting in the deemed cancellation of the old options.